Home / Investors / Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 19 out of 19 posts.

25 Nov, 2024

Enrollment completed five months early in the US clinical trial evaluating XVIVO’s heart preservation technology

14 Nov, 2024

XVIVO Perfusion appoints Lena Hagman as deputy CEO

24 Oct, 2024

Interim report January-September 2024

10 Oct, 2024

Conference call on Interim Report

19 Sep, 2024

XVIVO to acquire a unique communication platform for the transplant process

6 Sep, 2024

Nomination Committee of XVIVO Perfusion AB (publ)

16 Aug, 2024

Results from European randomized controlled study using XVIVO’s heart technology published in The Lancet

12 Jul, 2024

Interim report January – June 2024

25 Jun, 2024

Conference call on Interim Report

25 Apr, 2024

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)

24 Apr, 2024

Interim report January-March 2024

11 Apr, 2024

Results from XVIVO’s clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague

8 Apr, 2024

Conference call on Interim Report

4 Apr, 2024

Annual Report 2023

21 Mar, 2024

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN XVIVO PERFUSION AB (PUBL)

29 Feb, 2024

The first-ever transplantation with a donor heart transported across the Atlantic Ocean – made possible by the use of XVIVO’s heart technology

25 Jan, 2024

XVIVO presents Report on Operations 2023

24 Jan, 2024

Extended perfusion time of livers can streamline planning and logistics – enabling more liver transplants to be performed during daytime

12 Jan, 2024

Conference call on Report on Operations 2023